WallStreetZenWallStreetZen

NASDAQ: NLSP
Nls Pharmaceutics Revenue

OverviewEarningsRevenue
DividendOwnership
Nls Pharmaceutics revenue was $0.00 for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, NLSP annual revenue was $0.0, with N/A growth year-over-year.

NLSP revenue history

Current Revenue
$0.0
Current Earnings
-$6.6M
Current Profit Margin
0%

Be the first to know when NLSP announces revenue.

NLSP Revenue History By Year

NLSP Yearly RevenueNLSP RevenueNLSP ChangeNLSP Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Nls Pharmaceutics Revenue FAQ

What was NLSP's revenue last quarter?

Nls Pharmaceutics (NASDAQ: NLSP) reported Q2 2024 revenue of N/A up N/A year over year. In the same quarter last year, Nls Pharmaceutics's revenue was N/A.

What was Nls Pharmaceutics's revenue in 2023?

Nls Pharmaceutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Nls Pharmaceutics make in a day?

Based on Nls Pharmaceutics annual revenue for the past five years, NLSP makes an average of $0.00 per day.

What was Nls Pharmaceutics's annual revenue growth in the past year?

As of Q2 2025, Nls Pharmaceutics's revenue has grown null year over year. Nls Pharmaceutics's revenue in the past year totaled $0.00.

How much does Nls Pharmaceutics make in a year?

Nls Pharmaceutics's revenue by year for the past five years is:
  • Nls Pharmaceutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Nls Pharmaceutics's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
  • Nls Pharmaceutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Nls Pharmaceutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
  • Nls Pharmaceutics's annual revenue for 2019 was $0.00, a N/A decrease from 2018.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.